Replies to post #16484 on BioCurex, Inc.(fka BOCX)

[Gold Seeker]

Opportunity, they were testing ADVANCED stage cancers and only detected 89%. At that stage of cancer, you probably be that accurate with a doctors exam. The huge question is why did Dr. Pennington use advanced stage patients? You could easily conclude that earlier stage patients were not included in the study because too many would not test positive.

[1nvestor]

O.K.

"I am sorry Great Grandma, Erthang, and Mysscat and the many other shareholders that were scared of losing their investment by following the OPINIONS of lay individuals that spend 24/7 to convince you that recaf is not viable."

I did not know that Erthang sold. Missed that -- where was that written? I have bought over time and have not sold since the price was over $2.25.

[mcd2inga]

Opp,
<<<I would bet the farm that he is thinking about testing for recaf in urine? Anyone else agree?>>>

I was thinking the same thing, but not in a good way. I hate to be negative but what's next after urine, hair samples, fingernails, etc.

I'm not going to get excited again until we see major developments from licensees, significant patents, paying off Smithline, or hints from independent sources of revenue potential. The PR's of new test formats have not helped the share price.

[Kag]

Opportunity Knocking,
You posted: "I would say that today is yet another game changer. Another significant achievement."

My comment: What on Earth are you talking about? Do you really think that today's press release was a "game changer" or somehow a significant achievement? Do you not understand that the cancer patients used in the study already had widespread cancer. Thus, there was no need for any universal cancer test to be used to detect it. Do you think that doctors would have trouble diagnosing widespread cancer in a patient? kag